Ligand Pharmaceuticals
LGND
LGND
227 hedge funds and large institutions have $2.34B invested in Ligand Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 56 increasing their positions, 106 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
47% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 106
50% less call options, than puts
Call options by funds: $54.2M | Put options by funds: $108M
78.78% less ownership
Funds ownership: 227.62% → 148.83% (-79%)
Holders
227
Holding in Top 10
5
Calls
$54.2M
Puts
$108M
Top Buyers
| 1 | +$24.5M | |
| 2 | +$19.7M | |
| 3 | +$17.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.04M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$9.02M |
Top Sellers
| 1 | -$146M | |
| 2 | -$114M | |
| 3 | -$108M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$62.6M |
| 5 |
State Street
Boston,
Massachusetts
|
-$58.3M |